| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.06▲ | 5.07▼ | 5.09▼ | 4.83▲ | 4.60▲ |
| MA10 | 5.07▼ | 5.08▼ | 5.03▲ | 4.60▲ | 5.01▲ |
| MA20 | 5.07▼ | 5.00▲ | 4.91▲ | 4.54▲ | 5.79▼ |
| MA50 | 5.08▼ | 4.79▲ | 4.59▲ | 5.05▲ | 5.68▼ |
| MA100 | 5.02▲ | 4.57▲ | 4.53▲ | 5.80▼ | 5.71▼ |
| MA200 | 4.91▲ | 4.50▲ | 4.80▲ | 5.69▼ | 4.92▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.008▼ | 0.003▲ | 0.119▲ | -0.158▼ |
| RSI | 48.785▼ | 65.426▲ | 69.366▲ | 56.235▲ | 44.755▼ |
| STOCH | 27.706 | 56.260 | 77.030 | 58.067 | 21.497 |
| WILL %R | -63.636 | -38.000 | -25.676 | -34.528 | -67.771 |
| CCI | 7.035 | 29.232 | 64.307 | 138.277▲ | -65.221 |
|
Friday, November 14, 2025 05:00 AM
ABEO READ THE FULL ABEO RESEARCH REPORT Business Update First Patient Treated with Zevaskyn® Pushed to 4Q25 The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 ...
|
|
Thursday, November 13, 2025 05:16 AM
Operator: Good morning, everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, all participants are in a listen-only mode.
|
|
Wednesday, November 12, 2025 01:00 PM
Abeona Therapeutics Inc (ABEO) reports significant progress in ZivaSkin's commercial launch and market access, despite facing delays in patient treatments and a decrease in R&D spending.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 5.15 | 5.15 | 5.04 | 5.07 | 524,402 |
| 26/11/25 | 4.83 | 5.17 | 4.80 | 5.15 | 2,550,315 |
| 25/11/25 | 4.63 | 4.91 | 4.60 | 4.88 | 1,841,000 |
| 24/11/25 | 4.46 | 4.63 | 4.42 | 4.59 | 1,306,408 |
| 21/11/25 | 4.21 | 4.57 | 4.19 | 4.48 | 1,813,882 |
| 20/11/25 | 4.21 | 4.35 | 4.16 | 4.22 | 1,843,228 |
| 19/11/25 | 4.47 | 4.47 | 4.16 | 4.20 | 2,073,227 |
| 18/11/25 | 4.48 | 4.58 | 4.395 | 4.48 | 1,545,817 |
| 17/11/25 | 4.41 | 4.625 | 4.39 | 4.51 | 2,112,209 |
| 14/11/25 | 4.50 | 4.59 | 4.37 | 4.45 | 2,636,100 |
|
|
||||
|
|
||||
|
|